supported by the National Cancer Institute(NCI)MERIT Award(R37CA255459 to X.M.);NCI Emory Lung Cancer SPORE(P50CA217691 to H.F.)Career Enhancement Program(P50CA217691 to X.M.);NCI Emory Lung Cancer P01(P01CA257906 to H.F.);NCI Office of Cancer Genomics Cancer Target Discovery and Development(CTD2)initiative network(U01CA217875 to H.F.);Winship Cancer Institute(NIH 5P30CA138292).
The transforming growth factor-beta(TGFβ)signaling pathway plays crucial roles in the establishment of an immunosuppressive tumor microenvironment,making anti-TGFβagents a significant area of interest in cancer immu...
supported in part by the Emory School of Medicine COVID Catalyst-I3 award(H.F.and S.G.S.);the NCI Emory Lung Cancer SPORE(P50CA217691)Career Enhancement Program(A.A.I.);Emory Initiative on Biological Discovery through Chemical Innovation(A.A.I.);R01AI167356(S.G.S.).
SARS-CoV-2,the coronavirus that causes the disease COVID-19,has claimed millions of lives over the past 2 years.This demands rapid development of effective therapeutic agents that target various phases of the viral re...
the National Natural Science Foundation of China(91853205 and 81625022 to CL,81430084 to DHD);KC Wong Education Foundation to CL,Chinese Academy of Sciences(XDA12020353 to CL and CASIMM0120184015 to HZ);China Postdoctoral Science Foundation(2017M621571 to LYY);Science and Technology Commission of Shanghai Municipality(18431907100 and 19XD1404700 to CL);National Science&Technology Major Project of China(2018ZX09711002 to DHD).
The cAMP-responsive element binding protein(CREB)binding protein(CBP)and adenoviral E1A-binding protein(P300)are two closely related multifunctional transcriptional coactivators.Both proteins contain a bromodomain(BrD...
supported by the National Natural Science Foundation of China(81270947 and 81570763,to XX);the National Program on Key Basic Research Project of China(973 Program,2012CB517505,to XX);the Fundamental Science and Advanced Technology Research of Chongqing(Major Project,CSTC2015jcyjB0146);Chongqing Graduate Student Research Innovation Fund(CYB15095,to HY)。
Traditional thiazolidinediones(TZDs),such as rosiglitazone,are peroxisome proliferator-activated receptor g(PPARg)potent agonists that can be used to treat type 2 diabetes but carry unwanted effects,including increase...